Stay updated on ARGX-113 in ITP Patients Clinical Trial
Sign up to get notified when there's something new on the ARGX-113 in ITP Patients Clinical Trial page.

Latest updates to the ARGX-113 in ITP Patients Clinical Trial page
- Check6 days agoChange DetectedThe footer revision identifier changed from v3.7.2 to v3.8.0. The study record remains inaccessible behind a 403 Forbidden error.SummaryDifference0.2%

- Check12 days agoChange DetectedA banner announces an NIH-wide transition from using “Artificial Intelligence” to “Super Intelligence” terminology and links to updates and FAQs.SummaryDifference1%

- Check19 days agoChange DetectedThe ClinicalTrials.gov footer revision changed from v3.7.1 to v3.7.2, while the page continues to display a 403 error.SummaryDifference0.2%

- Check26 days agoChange DetectedThe site footer’s revision identifier changes from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check47 days agoChange DetectedThe page now displays a 403 Forbidden error page, replacing the study content with a simple header and a Home button. This indicates the record is currently inaccessible.SummaryDifference17%

- Check61 days agoChange DetectedNo additions or deletions are described for this page. There are no textual changes to interpret in context.SummaryDifference0.0%

Stay in the know with updates to ARGX-113 in ITP Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ARGX-113 in ITP Patients Clinical Trial page.